Twist Stock Analysis


USD 49.88  6.68  11.81%   

The newest price gain of Twist Bioscience created some momentum for private investors as it was traded today as low as 49.81 and as high as 54.85 per share. The company executives may have good odds in positioning the company resources to exploit market volatility in September. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.85. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Twist Bioscience Corp partners.
Additionally, take a look at World Market Map.
The Twist Bioscience stock analysis report makes it easy to digest most publicly released information about Twist Bioscience and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Twist Stock analysis module also helps to analyze the Twist Bioscience price relationship with some important fundamental indicators such as market cap and management efficiency.

Twist Stock Analysis Notes

About 107.0% of the company shares are owned by institutional investors. The book value of Twist Bioscience was at this time reported as 15.35. The company recorded a loss per share of 3.72. Twist Bioscience Corp had not issued any dividends in recent years. Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California. Twist Bioscience operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 652 people. To find out more about Twist Bioscience Corp contact Emily Leproust at 800 719-0671 or learn more at

Twist Bioscience Corp Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Twist Bioscience's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Twist Bioscience Corp or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Twist Bioscience is way too risky over 90 days horizon
Twist Bioscience appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 163.11 M. Net Loss for the year was (187.51 M) with profit before overhead, payroll, taxes, and interest of 51.71 M.
Twist Bioscience Corp currently holds about 573.86 M in cash with (151.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.2.
Twist Bioscience has a frail financial position based on the latest SEC disclosures
Latest headline from MacroaxisInsider: Payment of 305 shares by Patrick Finn of Twist Bioscience subject to Rule 16b-3

Twist Bioscience Corp Upcoming and Recent Events

Earnings reports are used by Twist Bioscience to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Twist Bioscience previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report3rd of February 2022
Next Financial Report5th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End28th of November 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Twist Largest EPS Surprises

Earnings surprises can significantly impact Twist Bioscience's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Twist Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 2.59 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Twist Bioscience's market, we take the total number of its shares issued and multiply it by Twist Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Twist Profitablity

Twist Bioscience's profitability indicators refer to fundamental financial ratios that showcase Twist Bioscience's ability to generate income relative to its revenue or operating costs. If, let's say, Twist Bioscience is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Twist Bioscience's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Twist Bioscience's profitability requires more research than a typical breakdown of Twist Bioscience's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (114.96) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (120.31) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -1.2.
Last ReportedProjected for 2022
Return on Investment(29.77) (32.12) 
Return on Average Assets(24.87) (26.83) 
Return on Average Equity(29.85) (32.21) 

Management Efficiency

The entity has return on total asset (ROA) of (15.31) % which means that it has lost $15.31 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (25.38) %, meaning that it created substantial loss on money invested by shareholders. Twist Bioscience management efficiency ratios could be used to measure how well twist bioscience corp manages its routine affairs as well as how well it operates its assets and liabilities. Return on Investment is likely to drop to -32.12 in 2022. Return on Average Assets is likely to drop to -26.83 in 2022. Total Liabilities is likely to gain to about 117.8 M in 2022. Current Liabilities is likely to gain to about 61.2 M in 2022

Technical Drivers

As of the 9th of August, Twist Bioscience has the Risk Adjusted Performance of 0.2045, semi deviation of 5.44, and Coefficient Of Variation of 666.65. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Twist Bioscience Corp, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We are able to interpolate and collect nineteen technical drivers for Twist Bioscience Corp, which can be compared to its competition. Please validate Twist Bioscience Corp coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if Twist Bioscience is priced more or less accurately, providing market reflects its prevalent price of 49.88 per share. Given that Twist Bioscience Corp has jensen alpha of 1.04, we advise you to double-check Twist Bioscience Corp's current market performance to make sure the company can sustain itself at a future point.

Twist Bioscience Corp Price Movement Analysis

The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to Twist Bioscience Corp price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator.

Twist Bioscience Corp Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Twist Bioscience insiders, such as employees or executives, is commonly permitted as long as it does not rely on Twist Bioscience's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Twist Bioscience insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Patrick Finn over a week ago via Macroaxis 
Payment of 305 shares by Patrick Finn of Twist Bioscience subject to Rule 16b-3
William Banyai over two weeks ago via Macroaxis 
Payment of 201 shares by William Banyai of Twist Bioscience subject to Rule 16b-3
Cho Dennis over a month ago via Macroaxis 
Payment of 118 shares by Cho Dennis of Twist Bioscience subject to Rule 16b-3
Paula Green over a month ago via Macroaxis 
Exercise or conversion by Paula Green of 2531 shares of Twist Bioscience subject to Rule 16b-3
Yankton Kevin Bruce over two months ago via Macroaxis 
Payment of 235 shares by Yankton Kevin Bruce of Twist Bioscience subject to Rule 16b-3
Barthelemy Nicolas over two months ago via Macroaxis 
Purchase by Barthelemy Nicolas of 8550 shares of Twist Bioscience
Patrick Finn over three months ago via Macroaxis 
Payment of 305 shares by Patrick Finn of Twist Bioscience subject to Rule 16b-3
James Thorburn over three months ago via Macroaxis 
Exercise or conversion by James Thorburn of 1517 shares of Twist Bioscience subject to Rule 16b-3
James Thorburn over three months ago via Macroaxis 
Exercise or conversion by James Thorburn of 2000 shares of Twist Bioscience subject to Rule 16b-3
James Thorburn over three months ago via Macroaxis 
Exercise or conversion by James Thorburn of 1517 shares of Twist Bioscience subject to Rule 16b-3
Patrick Finn over three months ago via Macroaxis 
Payment of 1027 shares by Patrick Finn of Twist Bioscience subject to Rule 16b-3
Jan Johannessen over three months ago via Macroaxis 
Exercise or conversion by Jan Johannessen of 5000 shares of Twist Bioscience subject to Rule 16b-3

Twist Bioscience Predictive Daily Indicators

Twist Bioscience intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Twist Bioscience stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Twist Bioscience Forecast Models

Twist Bioscience time-series forecasting models is one of many Twist Bioscience's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Twist Bioscience's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Twist Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Twist Bioscience stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Twist shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Twist Bioscience. By using and applying Twist Stock analysis, traders can create a robust methodology for identifying Twist entry and exit points for their positions.
Last ReportedProjected for 2022
Gross Margin 35.17  37.95 
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California. Twist Bioscience operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 652 people.

Current Twist Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Twist analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Twist analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Twist Bioscience Corp current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Twist analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Twist stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Twist Bioscience Corp, talking to its executives and customers, or listening to Twist conference calls.
Twist Analyst Advice Details

Twist Stock Analysis Indicators

Twist Bioscience Corp stock analysis indicators help investors evaluate how Twist Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Twist Bioscience shares will generate the highest return on investment. By understating and applying Twist Bioscience stock analysis, traders can identify Twist Bioscience position entry and exit signals to maximize returns.
Quick Ratio7.19
Fifty Two Week Low25.07
Revenue Growth54.20%
Average Daily Volume Last 10 Day845.01k
Shares Short Prior Month6.26M
Average Daily Volume In Three Month1.25M
Shares Percent Shares Out11.84%
Gross Margins38.57%
Forward Price Earnings-10.13
Short Percent Of Float11.95%
Float Shares53.94M
Fifty Two Week High139.99
Fifty Day Average37.19
Enterprise Value To Ebitda-10.36
Two Hundred Day Average60.52
Enterprise Value To Revenue12.47
Additionally, take a look at World Market Map. Note that the Twist Bioscience Corp information on this page should be used as a complementary analysis to other Twist Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Twist Stock analysis

When running Twist Bioscience Corp price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Is Twist Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine Twist Bioscience value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.